Velázquez-Hernández María-Elena

Velázquez-Hernández María-Elena

Auto-generated profile, based on publicly available information

Velázquez-Hernández María-Elena

Clínica de Enfermedades Crónicas y Procedimientos Especiales, Morelia, Michoacán, Mexico

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 March 2020 in Archives of Dermatological Research
Verified
Journal Article
Closed access
PDF file
CCCervantes-Durán Claudia
Cervantes-Durán Claudia
VMVelázquez-Hernández María-Elena
Velázquez-Hernández María-Elena
VJValentín-Escalera Josué
Valentín-Escalera Josué
MBMaría Carmen Bartolome-Camacho
María Carmen Bartolome-Camacho
ARAlain R Rodríguez-Orozco
Alain R Rodríguez-Orozco
Martha-Estrella García-PérezMartha-Estrella García-Pérez
Martha-Estrella García-Pérez

1 March 2026 in Journal of Pharmacy & Pharmacognosy Research
Verified
Journal Article
Open access
MGMarwan Gagaa
Marwan Gagaa
Roberto Esquivel-GarcíaRoberto Esquivel-García
Roberto Esquivel-García
MVMaría E. Velázquez-Hernández
María E. Velázquez-Hernández
IBIsis B. Bermúdez-Camps
Isis B. Bermúdez-Camps
Martha-Estrella García-PérezMartha-Estrella García-Pérez
Martha-Estrella García-Pérez
Martha-Estrella García-PérezMartha-Estrella García-Pérez
Martha-Estrella García-Pérez
Context: Medicinal plants have been widely used for psoriasis management for centuries. However, their safety profiles remain insufficiently documented. Aims: To systematically evaluate adverse events (AEs) and potential pharmacokinetic interactions of antipsoriatic herbal treatments. Methods: A PRISMA-compliant review was conducted using PubMed, Cochrane, Google Scholar, Web of Science, and Scopus databases (January 2015-December 2022). Clinical trials, case reports, and ethnomedicinal studies reporting AEs of single plant antipsoriatic preparations were included. CONSORT criteria for herbal medicines were applied to assess study quality. Results: Eleven studies covering nine herbal treatments were included. While most of reported AEs were mild, severe cases involving Indigo naturalis, Psoralea corylifolia, and Ranunculus arvensis were documented. Several herbal metabolites (indirubin, psoralen, curcumin, triptolide) showed potential pharmacokinetic interactions with conventional drugs. Conclusions: While generally well tolerated, antipsoriatic herbal therapies can induce mild to severe AEs and may alter drug metabolism. Long-term, high-quality randomized trials are needed to establish their safety profile.